Effect of CsA on the expression of refill and angiotensin type 1 receptor genes in the rat kidney. To determine whether Cyclosponne A (CsA) alters the intrarenal expression of the renin and type 1 angiotensin II receptor genes, male adult Sprague-Dawley rats were given 25 mg/kg! day CsA s.c. for three weeks (CsA, N = 20) and were compared to pair-fed vehicle treated rats (Con, N = 20). The intrarenal distribution of renin and its mRNA was assessed by immunocytochemistry and in situ hybridization. In addition, kidney renin and type 1 angiotensin II (AT1) receptor mRNA levels were determined by Northern blot analysis. The percentage of juxtaglomerular apparatuses containing renin was higher in the CsA (84 5.5%) than in the Con (61 6.7%) group, (P < 0.05). The length of renin immunostaining along afferent arterioles was higher in the CsA (74 4.5 m) than in the Con (37 5.1 m) group, (P < 0.05). In contrast, neither renin mRNA levels nor its intrarenal distribution were altered by chronic CsA administration.
juxtaglomerular apparatus have been observed in animals treated with CsA [18] [19] [20] . In addition, renin release from cortical slices and isolated juxtaglomerular cells is enhanced by CsA [21, 22] . Micropuncture studies demonstrate that CsAinduced reductions in whole kidney and single nephron filtration and blood flow rates are associated with a decreased net filtration pressure, together with an altered ratio of afferent and efferent arteriolar resistances [9, 23, 24] , suggesting an alteration of local angiotensin II activity.
Whereas the available evidence suggests that CsA affects the intrarenal RAS, it is unknown whether CsA alters the intrarenal distribution of renin and/or its mRNA. Furthermore, it is unknown whether CsA affects the expression of angiotensin II receptors. Therefore, the present study was designed to determine whether chronic CsA administration alters the intrarenal expression of the renin and type 1 angiotensin receptor (AT1) genes. The intrarenal distribution of renin and renin mRNA was determined using immunocytochemistry and in situ hybridization histochemistry, respectively. Additionally, kidney renin and AT1 mRNA levels were assessed by Northern and dot blot analysis.
Methods
Male Sprague-Dawley rats (Taconic Farms) weighing 135 to 150 g were injected daily (s.c.) for 21 days with 25 mg/kg/day CsA oral solution diluted with olive oil (CsA, N = 20) or an equivalent amount of vehicle (Con, N = 20). Food consumption was restricted in the Con animals to the average amount consumed by the CsA treated rats. This simplified pair-feeding protocol resulted in similar body weights in CsA (265 8.4 g) and Con (263 7.1 g) groups at the time of experimentation.
Animals were anesthetized with mactin (100 mg/kg, i.p.). The right femoral artery was catheterized with a P-SO polyethylene tube for blood pressure measurement and blood sampling. PRA was determined by radioimmunoassay [25] in 10 animals from each group. Renal renin concentration (RRC) was determined by radioimmunoassay [25] in homogenates of left kidneys of 10 rats in each group. Angiotensin I (Al) generated after incubation of renal homogenates for 30 minutes at pH 6. 
Renin immunocytochemistry
Kidneys from five animals in each group were perfused with 0.9% saline (20 ml) and 10% buffered formaldehyde (40 ml), removed, decapsulated and processed for immunocytochemistry as previously described [26] . Kidneys were paraffin embedded and serial sagittal sections (5 to 7 sm) were cut. Immunocytochemical detection of renin was performed with the avidinbiotin immunoperoxidase method [27] . The primary antibody was a specific polyclonal anti-rat renin antibody raised in rabbits (gift of Dr T, Inagami, Vanderbilt University), diluted 1:2500 [28] . The secondary antibody was a biotin-conjugated anti-rabbit IgG raised in goats. Kidney sections were incubated with avidin-horseradish peroxidase complex (Vectastain ABC kits, Vector Laboratory, Burlingame, California, USA), exposed to 0.1% diaminobenzidine tetrahydrochloride and 0.02% }1202 as a source of peroxidase substrate and counterstained with hematoxylin. Negative controls as indicated by absence of staining included: (1) omission of the primary antibody, (2) replacement of secondary antibody with non-immune rabbit serum, and (3) omission of secondary antibody.
Three sections per animal were immunostained and examined with light microscopy. The total number of juxtaglomerular apparatuses (JGA) and those positively stained were counted in each section. The total visible length of afferent arterioles (AA) and the length positively stained were measured with an ocular micrometer. Since the number of glomeruli, JGA and AA varied from section to section, immunoreactive ream was expressed as percent of JGA (%JGA) and percent of AA (%LAA) positively stained [32] . The ratios obtained from each slide were pooled and averaged for each animal.
Renin messenger RIJA levels and localization Kidney levels and intrarenal distribution of renin mRNA were determined by Northern blot analysis and in situ hybridization histochemistry, respectively. Total RNA was extracted from the right kidneys of ten rats in each group according to the method of Chirgwin eta! [29] . The RNA was dissolved in sterile water and stored at -80°C until use. RNA concentration was measured by spectrophotometry at 260 nm. Total RNA was resolved by electrophoresis on 1.2% agarose-formaldehyde gels and transferred to nylon membranes (Zetabind, Cuno mc, Meriden, Connecticut, USA) by capillary action. In addition, dot blots were prepared with kidney total RNA from CsA (N = 10) and Con (N = 10) rats. Northern and blots were hybridized by the method of Church and Gilbert [301 with a full-length rat kidney renin cDNA (gift of K. Lynch, University of Virginia) labeled with 32P by nick translation [31] (sp. activity 1.83 x 10' cpm4g) or by random priming [34] (sp. activity 2.3 x io cpm/Lg). Hybridization signals were detected by autoradiography and quantified by scanning densitometry (LKB 2222-020 Ultra Scan XL Laser densitometer, Bromma, Sweden). In situ hybridization histochemistry Five rats from each group were anesthetized with pentobarbital sodium (3 mg/100 g body wt i.p.) and kidneys were prepared for in situ hybridization histochemistry, as previously described with few modifications [26, 32] . Briefly, kidneys were perfused with 4% paraformaldehyde in 0.12 M sodium phosphate, postfixed for one hour in the same solution and stored overnight at 4°C in cryoprotection solution (30% sucrose in 0.12 M sodium phosphate). Frozen sagittal sections (14 jsm) were cut and mounted on positively charged slides. Sections were prehybridized for one hour at 37°C and hybridized for 24 hours at 37°C to an oligonucleotide complementary to nucleotides 313 to 340 of rat renin mRNA [32] . The oligonucleotide was labeled at the 3' end with -thio-35S-dATP to a specific activity of 1.46 x iO counts min pmol '. After hybridization, the sections were washed in decreasing concentrations of SSPE (lx SSPE in 150 ifiM NaC1, 10 ifiM Na2HPO4 and 1 mM EDTA, pH 7.4) containing 14 mai 2-mercaptoethanol and 1% sodium thiosulfate, followed by a high stringency wash at 51°C for 30 minutes in 0.1 x SSPE. Then, sections were dehydrated, submitted to emulsion autoradiography and stained with hematoxylin. Negative controls as indicated by absence of hybridization signals were: (1) omission of the probe, and (2) hybridization with sense 35S-labeled oligonucleotide. All slides from Con and CsA treated animals were processed simultaneously.
In situ hybridization signals were counted by computer digitization (Gould 1P8500, Biomedical Engineering, University of Virginia) in three sections per animal. The number of JGA with hybridization signals and the total number of JGA were counted and calculations were made as described for immunocytochemistry. In addition, the number of silver grains over each JGA was computed for each section and an average was obtained for each animal. However, since the number of grains varied among sections and animals within a group, frequency distribution polygons were used to further assess the grain population in the CsA and Con groups.
Renal AT1 receptor ,nessenger RNA level Kidneys from five CsA and five Con rats were pooled and total RNA resolved by agarose gel electrophoresis as described above. Dot blots were prepared with kidney total RNA from individual CsA (N = 5) and Con (N = 5) rats. Northern and dot blots were hybridized by Church and Gilbert's method [30] with a 1133 base pair fragment of rat AT1 receptor cDNA (a gift of K. Lynch, University of Virginia) [33] labeled with 32PdCTP to a specific activity of 2.7 x l0 cpmIpg by random priming [34] . AT1 cDNA was obtained as follows: two oligonucleotides 
Results
Mean arterial pressure was higher in CsA (118 5.3 mm Hg) than in Con rats (102 1.8 mm Hg; P < 0.05). Plasma renin activity was higher in CsA (7.9 1.37 ng AJJmlIhr) than in Con rats (4.1 0.59 ng AI/ml/hr; P < 0.05). Renin content in whole kidney homogenate was higher in CsA (4.6 0.36 x iO ng AI/hr/g kidney) than in Con (3.64 0.24 x 1O ng AIIhr/g C kidney; P < 0.05). These data indicate that three weeks of CsA administration to rats was associated with the development of hypertension and stimulation of the local renin-angiotensin system.
Renin immunocytochemistry These oligonucleotides were used to amplify, by the polymerase chain reaction (PCR), a 1133 base pair fragment (nudeotides #-44-1089) of cDNA encoding the rat AT1 receptor [33] . The conditions for the PCR were 94°C for one minute, 55°C for two minutes, and 72°C for three minutes repeated for 25 cycles.
The DNA was amplified from approximately 1 ng of cDNA synthesized from rat liver poly ARNA (Amersham cDNA synthesis kit). The specific fragment was purified from an agarose gel by electrophoresis onto DEAE-cellulose [35] and either used as the hybridization probe directly or subcloned into the Smal site of pOEM 7(z)f(+). Hybridization signals were detected by autoradiography and quantitated by scanning densitometry (LBK 2222-020 Ultrascan XL Laser densitometer, Bromma, Sweden).
Statistical analysis
Comparison between blood pressure, plasma renin activity, histochemical ratios and grain counts of CsA and Con groups D The distribution of renin within the kidney of Con and CsA treated rats is shown in Figures 1 and 2 . Renin immunoreactivity was markedly enhanced in CsA (Fig. 1 ) when compared to Con (Fig. 2) . The intrarenal distribution of renin was altered in the CsA group (Fig. 1) . Immunoreactive renin was observed along afferent arterioles upstream from the glomerulus in the CsA group whereas it was limited to the classical juxtaglomerular location in the Con group. The mean length of AA immunostaining was higher in CsA (74.1 4.47 m) than in the Con group (37 5.12 pm; P < 0.05). Also, the %LAA was higher in CsA (64 5.4%) than in Con (25 1.3%), (P < 0.05). Moreover, the %JGA was higher in CsA (84 5.5%) than in Con (61 6.7%; P < 0.05). Figure 3 shows representative autoradiograms of Northern and dot blots demonstrating that renin mRNA levels were not altered in the CsA group. Quantification by optical densitometry measurements demonstrated the similarity between the two groups.
Intrarenal renin mRNA levels and distribution
The intrarenal distribution of renin mRNA was not significantly altered in the CsA group. Hybridization signals were limited to the kidney cortex and localized in the juxtaglomerular apparatuses and the adjacent portion of afferent arterioles in both groups of rats ( Figs. 4 and 5) . No extension of hybridization signals along afferent arterioles was observed. The %JGA containing hybridization signals was similar in the CsA (50 7.1%) and in the Con group (41 4 .1%). The intensity of hybridization signals, a function of the mRNA content per JGA, was similar in CsA (274 51 grains/JGA) and in Con (293 38 grains/JGA). Figure 6 depicts the distribution of grains per JGA in CsA and Con groups. The curves plotted are superposed and no significant difference between the two groups was detected by chi-square analysis.
Renal AT1 receptor mRNA
The decrease of kidney AT1 mRNA induced by chronic CsA treatment is shown in Figure 7 . The autoradiograms demonstrate that renal steady state AT1 mRNA level is significantly lower in CsA than in Con rats. 
Discussion
The present study demonstrates that chronic CsA treatment in rats: (1) increases circulating and renal renin, (2) alters the intrarenal distribution of renin, (3) does not modify renin mRNA levels nor its intrarenal distribution, and (4) downregulates AT1 receptor gene expression.
Our findings of elevated mean arterial pressure, plasma renin activity and renal renin content indicate that RAS activity is enhanced both locally and systemically in CsA-treated rats. These results are in agreement with previous reports showing elevations of plasma renin activity and renal renin concentration in rats treated with varying doses of CsA for shorter periods of time [10, 13, 181 . Quantitative differences in renal renin content between the present study and previous reports are likely to be due to the fact that renin content was measured in whole kidney homogenates in the present study. Alternatively, renin storage may have been affected differently by the various doses, species of experimental animal, duration of treatment and routes of administration of CsA [10] .
The immunocytochemical data of the present study demonstrate that CsA alters the intrarenal distribution of renin.
CsA-induced enhancement of intrarenal vascular renin may account for the aforementioned increase in renal renin content. Our specific immunocytochemical staining confirms and extends previous light microscopy observations of JGA hyperplasia and increased granule-containing cells along afferent arteri-oles in CsA-treated animals [5, 201 . Taken together, these data suggest that CsA may induce increased renin synthesis. However, Northern blot analysis and in situ hybridization histochemistry demonstrate that neither renin mRNA content nor its distribution are altered after three weeks of CsA administration. The discrepancy between the intrarenal distribution of renin mRNA and its protein can be explained by several mechanisms operating singly or in combination. First, CsA may induce vascular uptake of renin. Previous studies have shown that the vasculature is capable of taking up circulating renin [36] .
Endothelial damage induced by CsA [6, 7] may have facilitated diffusion of renin into the arterial wall. Second, CsA may decrease protein turnover and cause it to accumulate within the vessel wall. Different isoforms of renin have diverse metabolic clearance rates and functions [40] . During chronic stimulation of the RAS, acidic isoforms of renin having the longest half-life have been shown to increase [40] . It remains to be determined whether different renin isoforms are present in and/or released from the renal vasculature of CsA-treated rats. Third, renin gene expression may have varied during the time course of CsA treatment. Fourth and less likely, CsA may decrease renin mRNA half-life and therefore renin mRNA accumulation [37] .
Further studies are necessary to elucidate the mechanism(s) regulating renin synthesis and metabolism in response to CsA.
The present study demonstrates that AT1 receptor gene expression is downregulated in the kidney following chronic CsA treatment in the rat. It is possible that high local levels of gering the molecular alterations described in the present study Ang II modulate AT1 gene expression. This hypothesis, how-remain to be determined. CsA raises sympathetic nervous ever, remains to be tested. The physiologic mechanisms trig-system activity in humans and animals [11, 19] and stimulates endothelial factors that may modulate the vascular RAS, that is, eicosanoids and endothelin [41] . Although sympathetic stimulation may account for the enhanced activity of intrarenal RAS [42] , it has been shown that renal denervation only partially reverses the renal vasoconstriction following acute and chronic CsA-treatment [9, 14] . Therefore, other stimuli, including macula densa activation and/or the renal baroreceptor mechanism are likely to be involved in the local activation of RAS in this model. Renal hypoperfusion, acutely determined by enhanced endothelin [15, 16] and/or thromboxane [12] activities, is the most likely initial trigger for intrarenal RAS activation.
Although acute experimental CsA-induced renal vasoconstriction is blocked by angiotensin converting enzyme inhibition [44] , numerous studies have shown that acute blockade of the intrarenal RAS only partially reverses more chronic CsA vasoconstriction [8, 9, 231 . Indeed, chronic angiotensin converting enzyme inhibition with enalapril during CsA administration worsened CsA-induced JGA hyperplasia and the resultant tubulointerstitial disease [45] . Therefore, there may be significant functional differences in the activation and regulation of the intrarenal RAS that are dependent on the length of exposure to varying doses of CsA. The alterations in renin and AT1 gene expression described in CsA treated rats may be responsible, at least in part, for some of the CsA-induced changes in renal vascular reactivity and autoregulation previously observed in this model [8, 23] . In addition, downregulation of AT1 receptors may provide the molecular basis for the blunted vascular response to acute infusions of Ang II in vitro [43] and for the "relative All insufficiency" state described in CsA treated rats [9] . Downregulation of AT1 mRNA may also represent an adaptive mechanism attempting to attenuate both glomerular and systemic hypertension.
Extrapolation of our results in a relatively short-term model of CsA treatment to chronic CsA nephropathy seen in humans after prolonged administration is tenuous. Nevertheless, CsAassociated arteriolopathy occurs in afferent arterioles of humans where hyperplasia of the JGA has been reported [10] . Thus, it is possible that early activation of the intrarenal RAS by CsA may be one of the numerous important events in the subsequent development of the more chronic renovascular changes that often occur with long-term CsA treatment.
In summary, the present investigation demonstrates that short-term chronic CsA administration in the rat is characterized by intrarenal expression of renin and AT1 receptor genes.
First, CsA resulted in recruitment of renin containing cells along afferent arterioles. Second, intrarenal renin mRNA levels and distribution were not altered by chronic CsA treatment, suggesting that renin content may be controlled by post-transcriptional events. Finally, CsA-induced downregulation of AT1 receptor gene expression in the kidney may contribute to the altered vascular reactivity of the renal vasculature in CsA-treated rats. D * 1 0
